Fenwick represented Standard AI on the deal. Standard AI, a developer of autonomous checkout technology designed to streamline operations for brick-and-mortar retailers, announced its definitive agreement to...
Standard AI’s Acquisition of Skip
Remitly’s Acquisition of Rewire
Fenwick represented Remitly on the deal. Remitly (NASDAQ: RELY), a global digital financial services provider for immigrants and their families, signed the agreement to acquire Rewire, an...
Emerson’s Acquisition of Fluxa
Fenwick represented Emerson on the deal. Emerson, a global technology and software company providing innovative solutions for customers in industrial, commercial and residential markets, announced its acquisition...
UBS’ Acquisition of Wealthfront
Fenwick & West and Willkie Farr & Gallagher advised Wealthfront on the deal. Wealthfront, an automated wealth management provider serving the next generation of investors, announced...
Remitly’s $522.9 Million IPO
Fenwick & West advised Remitly on the deal. Davis Polk advised several underwriters on the deal. Remitly Global, Inc. (Nasdaq: RELY), a mobile-first provider of remittances...
DICE Therapeutics’ $204 Million Initial Public Offering
Fenwick & West advised DICE Therapeutics on the deal. DICE Therapeutics (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of...
DiCE Molecules’ $60 Million Series C-1 Financing
Wilson Sonsini Goodrich & Rosati and Fenwick & West advised DiCE Molecules on the deal. DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform...